Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the disease

PURPOSE: Monitoring of key markers for lung cancer detection and tracking of acquired drug resistance is critical for the management of the disease. We aim to ascertain the value of monitoring both total cell free DNA concentrations and mutant EGFR DNA content within diverse groups of individuals mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zhangjing, Shah, Nirej, Deng, Chong, Xiao, Xuehui, Zhong, Tenglang, Li, Xiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844578/
https://www.ncbi.nlm.nih.gov/pubmed/27186495
http://dx.doi.org/10.1186/s40064-016-2141-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844578/
https://www.ncbi.nlm.nih.gov/pubmed/27186495
http://dx.doi.org/10.1186/s40064-016-2141-5

Ejemplares similares